Which members of Congress traded Gilead Sciences GILD recently?

The latest reported trades: Sen. Tommy Tuberville, purchase on 24/05/10 (reported 08/05), Sen. Tommy Tuberville, full sale on 24/05/08 (reported 08/05) and Sen. Alan Armstrong, purchase on 03/27 (reported 07/21).

Stocks

Gilead Sciences GILD

Health care sectorNasdaq

Close: $151.26; 09/29 close
Day change: −0.6%; vs previous close
Volume: 274,445; +19.9% vs 30-day average
52-week range: $108.55$157.17
1-year return: +34.4%; vs the close a year ago
Market cap: $187.6B; 1,239,955,155 shares · reported 07/31

Company

Exchange: Nasdaq
Sector: Health care
Industry: Biological Products, (No Diagnostic Substances)
Headquarters: Foster City, California
Fiscal year end: 12/31
Next earnings: 11/01, estimated

Members of Congress reported 5 trades in Gilead Sciences GILD in the past 90 days (4 purchases, 1 sale).

Korean holdings rank: Outside the top 50; Korea Securities Depository · released 09/22
Congress trades: 5; Last 90 days · 4 buys · 1 sales
Insider net buying: No record; Last 90 days · 0 buys · 0 sales
Dividendquarterly: $0.82 a share; Ex-dividend 09/15 · trailing yield 2.15% (4 dividends in 12 months over the 09/29 close)
Next earnings: 11/01; Estimated from the last four quarters

Price

$151.26Day −0.6%1 year +34.4%

26-week trading

Common questions

Which members of Congress traded Gilead Sciences GILD recently?: The latest reported trades: Sen. Tommy Tuberville, purchase on 24/05/10 (reported 08/05), Sen. Tommy Tuberville, full sale on 24/05/08 (reported 08/05) and Sen. Alan Armstrong, purchase on 03/27 (reported 07/21).